Products

Tirzepatide powder 2023788-19-2

Tirzepatide peptide for sale online as a weight loss drug is very popular in the market,its brand name is Mounjaro. Tirzepatide powder is the effective ingredient that use to make Tirzepatide lyophilized powder vial form. Tirzepatide peptide happens to be a dual-incretin mimetic that simultaneously activates the receptors of two hormones called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both are crucial to its potent weight loss effect. If you are looking for Tirzepatide powder, here is the right place you are.

Wisepowder has the capability to produce and supply large quantity. All production under cGMP condition and strict quality control system, all testing documents and sample available.
Category: SKU: 957875b729ac-1

Chemical Base Information 

NameTirzepatide
CAS2023788-19-2
Purity>98%
Chemical nameP1206, LY3298176
SynonymsP1206, LY3298176
Molecular FormulaC225H348N46O68
Molecular Weight4813.527 g/mol
Boling Point/
SequenceYE-Aib-GTFTSDYSI-Aib-LDKIAQ(C20 fatty acid)AFVQWLIAGGPSSGAPPPS
FormWhite powder
AppearancePowder, lyophilized powder
Half Life/
SolubilitySoluble in 50% aqueous acetoritrile
Storage ConditionStable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated.
Applicationweight loss, blood sugar control
Testing DocumentAvailable

Tirzepatide Peptide 2023788-19-2 General Description

Tirzepatide peptide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows Tirzepatide peptide for sale to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety, and accelerate weight loss. Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system and act as a potent weight loss agent. 

Tirzepatide Peptide 2023788-19-2 History

Tirzepatide peptide,sold under the brand name Mounjaro, is an antidiabetic medication used for the treatment of type 2 diabetes.Tirzepatide buy online is administered through subcutaneous injection (under the skin).

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood-sugar control. After a person has eaten, these hormones are secreted by cells of the intestines, and in turn cause the secretion of insulin. Tirzepatide for sale is a GIP-analogue that activates both the GLP-1 and GIP receptors, leading to improved blood-sugar control.

Tirzepatide peptide was approved for medical use in the United States in May 2022, in the European Union in September 2022,in Canada in November 2022,and in Australia in December 2022.The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Tirzepatide Peptide 2023788-19-2 Mechanism Of Action

Tirzepatide peptide works to target weight loss through its unique working mechanism. Primarily, it works as a glucagon-like peptide-1 receptor agonist (GLP-1RA) and glucagon receptor antagonist (GRA) dual agonist.

By stimulating GLP-1 receptors in the pancreas and gastrointestinal tract, Tirzepatide peptide for sale increases insulin secretion by the pancreas. Insulin helps regulate blood sugar levels and eases the process of the uptake of glucose by cells. Thereby it reduces blood glucose levels.

This is particularly beneficial for individuals with type 2 diabetes who often experience insulin resistance. We know how obesity and blood sugar levels are interrelated; therefore, by regulating blood sugar, Tirzepatide peptide online supports weight loss.

Additionally, Tirzepatide peptide buy online acts as a glucagon receptor antagonist, blocking the action of glucagon. It is a hormone released by the pancreas that can elevate blood sugar levels by promoting the release of glucose from the liver. Tirzepatide peptide reduces the liver’s glucose production by inhibiting glucagon, further aiding blood sugar control.

Furthermore, Tirzepatide peptide has been found to regulate appetite. Activation of GLP-1 receptors by Tirzepatide lyophilized powder induces feelings of satiety and reduces hunger, decreasing your food intake. This appetite-suppressing effect is particularly beneficial for individuals with obesity who struggle with overeating.

By targeting blood sugar control, insulin resistance, and appetite regulation, Tirzepatide provides a comprehensive approach to weight loss management in individuals with type 2 diabetes and obesity.

Tirzepatide Peptide 2023788-19-2 Application

Tirzepatide peptide for sale is a novel dual-incretin agonist that was recently approved as a medication for type 2 diabetes (T2D).

Currently, the Tirzepatide peptide shows superior glucose-lowering potency compared to other incretin mimetics, and it is under active investigation as a potential weight loss and cardioprotective agent.

If you’re a researcher looking to incorporate tirzepatide peptide into your work for research use, here is the best place to can know more about Tirzepatide sale, Tirzepatide price.

There are two main benefits of Tirzepatide peptide, include weight loss and treatment of type 2 diabetes (T2D).

Tirzepatide for weight loss use:

Tirzepatide for sale is a single molecule that activates the body’s receptors for GIP and GLP-1, which are natural incretin hormones. Both GIP and GLP-1 receptors are found in areas of the human brain important for appetite regulation. Tirzepatide for weight loss purpose has been shown to decrease food intake and modulate fat utilization.

Tirzepatide for type 2 diabetes

Tirzepatide peptide received FDA approval as an adjunct T2D intervention after successfully completing five of the phase-3 trials in the SURPASS global clinical development program.

These trials compared the efficacy of Tirzepatide 5mg, 10mg, and 15mg/weekly of tirzepatide to a placebo, a GLP-1 receptor agonist (1mg semaglutide), and two forms of basal (long-acting) insulin.

All three doses of tirzepatide (5mg, 10mg, and 15mg/weekly) had a superior effect on glycemic control and glycated hemoglobin (HbA1c) levels when compared to either placebo or semaglutide.

Further, the mean HbA1c reduction at different tirzepatide doses was greater by -0.29% to -0.92% when compared to semaglutide, and by -0.70% to -1.09% when compared to basal insulin regimens [23, 24, 25, 26, 27].

The largest trial, encompassing over 3000 participants and spanning 12 months, reported mean HbA1c changes from baseline of -2.43% at the 10mg dose of tirzepatide and -2.58% at the 15mg dose, whereas insulin glargine showed a change of -1.44%.

Tirzepatide Peptide 2023788-19-2 More research

Tirzepatide powder mixing instructions

Desperate for an affordable source of the new generation of potent anti-obesity drugs, some people have turned to a potentially dangerous technique: mixing their own semaglutide (Ozempic, Wegovy) or tirzepatide powder (Mounjaro) at home. How to mix Tirzepatide powder step by step?

Tirzepatide for research purposes is supplied as a lyophilized powder that needs to be reconstituted with an appropriate solvent like sterile water or bacteriostatic water.

The solvent should be chosen carefully as this will determine the peptide’s shelf-life once reconstituted. Overall, bacteriostatic water is the better option, as sterile water does not suppress microbial proliferation, making the peptide unsuitable for use within 24 hours.

Bacteriostatic water contains 0.9% benzyl alcohol, which has no toxicity at this concentration and acts as a suppressant of microorganism growth.

This enables the reconstituted peptide to remain viable for up to four weeks post-reconstitution when stored properly at a temperature range of 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit).

To ensure safety during reconstitution, it’s important to also follow standard precautions such as:

cleaning the tops of both the peptide and sterile water vials with alcohol wipes prior to reconstitution

using sterile needles and syringes to draw the solvent and inject it into the powder

slowly injecting the reconstituting liquid down the side of the vial to prevent foaming

After reconstitution, researchers can allow the solution to dissolve naturally or use sonication. Avoid shaking or tapping the vial, and do not freeze, heat, or expose it to direct sunlight.

We encourage researchers to visit our website to buy the Tirzepatide powder and Tirzepatide lyophilized powder according to different purchase use, in factory price and fast delivery. 

Is it safe to make Tirzepatide vials at home?

“It’s not safe to make it in your kitchen. It’s just not safe at all,” says Dr. is a trained pharmacist and healthcare consultant.

Tirzepatide as popular sale peptides in the weight loss market, many users choose to mixing Tirzepatide powder at home. But that is not recommend to do that. The regular Tirzepatide peptide manufacturer, must produce the Tirzepaitde under a strict GMP condition and have full quality control system. Have professional technology, equipment and personnel to ensure the Tirzepatide peptide at a high quality guarantee.

The U.S. Food and Drug Administration (FDA) warns consumers about the practice as well.

In a statement, the FDA said that “peptides marketed as ‘sold for research use’ … pose significant risks to patients because they have not been reviewed by the FDA before they are marketed to ensure safety, effectiveness or quality, and they are obtained without a prescription or prescriber oversight.”

Tirzepatide peptide Vs Mounjaro: Are they the same?

Mounjaro versus tirzepatide as a reference material are essentially different products that contain the same peptide. They differ by a few factors, including their intended use, pharmaceutical form, and price.

Mounjaro, a trade name by Eli Lilly and Co, is prescription-only tirzepatide marketed in the United States and intended for T2D management.

As such, it must be purchased at a pharmacy and is legally available only for patients with a valid prescription from a licensed healthcare provider. Those patients must adhere to the guidance of their physician and only use tirzepatide under medical supervision.

Mounjaro is available as an auto-injector pen that contains four doses and can deliver anywhere between 2.5mg-15mg/dose. Regardless of the amount delivered per dose, Mounjaro’s price is $1000-$1100 per pen or $250-$300 per dose.

Many patients have insurance coverage for using Mounjaro for T2D and may be eligible to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of the medication. Mounjaro for weight loss will generally not be covered by insurance.

Tirzepatide peptide is also available as a reference material that is intended for use only in experimental settings by qualified researchers and laboratory professionals. As a research peptide, tirzepatide for sale online can be purchased legally from reputable vendors like Wisepowder.

The cost of tirzepatide price as a reference material depends on the selected Tirzepatide manufacturer and it is not eligible for insurance coverage as the peptide is not intended for human use. The total Tirzepatide price also depends on the dose needed.

If you are looking for reliable Tirzepatide peptide manufacturer online, it is better to compare their quality, service…etc. Before buy bulk Tirzepatide.

Tirzepatide vs. Semaglutide: Similarities and Differences

People might ask, what is the difference between Tirzepatide and Semaglutide, are they the same?

Although both semaglutide and tirzepatide have been used in the treatment of type 2 diabetes, their mechanisms of action are not identical. Semaglutide is a GLP-1 (glucagon-like peptide 1) receptor agonist, while tirzepatide is a dual agonist. dual GIP/GLP-1 receptor co-agonist.

Some recent studies have compared semaglutide and tirzepatide for weight loss. A 2023 study found that tirzepatide resulted in greater weight loss than semaglutide. Although it costs more, researchers concluded that tirzepatide is more effective and a better value.

Tirzepatide Peptide 2023788-19-2 Reference

  1. Frederick MO, Boyse RA, Braden TM, Calvin JR, Campbell BM, Changi SM, et al. (2021). “Kilogram-Scale GMP Manufacture of Tirzepatide Using a Hybrid SPPS/LPPS Approach with Continuous Manufacturing”. Organic Process Research & Development. 25 (7): 1628–1636
  2. Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, et al. (December 2018).
  3. Zhao, F., Zhou, Q., Cong, Z., Hang, K., Zou, X., Zhang, C., Chen, Y., Dai, A., Liang, A., Ming, Q., Wang, M., Chen, L. N., Xu, P., Chang, R., Feng, W., Xia, T., Zhang, Y., Wu, B., Yang, D., Zhao, L., … Wang, M. W. (2022). Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Nature communications, 13(1), 1057.
  4. European Medicines Agency. 22 July 2022. Archived from the original on 28 July 2022. Retrieved 30 July 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.